Clinical trial
WENBIT - Western Norway B Vitamin Intervention Trial
NCT00354081 · Haukeland University Hospital, Other · Completed
Key facts
| NCT number | NCT00354081 |
|---|---|
| Title | WENBIT - Western Norway B Vitamin Intervention Trial |
| Official title | A Randomised Double Blind Study of the Effects of Homocysteine Lowering Therapy on Mortality and Cardiac Events in Patients Undergoing Coronary Angiography |
| Acronym | WENBIT |
| Lead sponsor | Haukeland University Hospital, Other |
| Collaborators | The Research Council of Norway Norwegian Foundation for Health and Rehabilitation Norwegian Heart and Lung Patient Organisation The Royal Norwegian Ministry of Health Locus for Homocysteine and… |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease, Myocardial Infarction, Cerebrovascular Stroke |
| Intervention type | Drug |
| Interventions | folic acid, vitamin B12 (cyanocobalamin), vitamin B6 (pyridoxine), placebo |
| Enrollment | 3,096 |
| Start date | Apr 1, 1999 |
| Primary completion | Jun 1, 2007 |
| Completion | Feb 1, 2008 |
| First posted | Jul 20, 2006 |
| Last update posted | Jul 12, 2013 |
| Countries | Norway |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: